Concert Pharma (CNCE) – Analyst Comments
-
Berenberg Positive on Concert Pharmaceuticals (CNCE), 'We expect CTP-543 will be commercialized as early as H2 2023'
-
Companies with NDRs 4/13
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CNCE Stock Lookup